BioNexus Gene Lab Corp. (NASDAQ:BGLC – Get Free Report) was the recipient of a significant drop in short interest in October. As of October 15th, there was short interest totalling 101,600 shares, a drop of 45.1% from the September 30th total of 185,200 shares. Approximately 0.9% of the company’s stock are sold short. Based on an average daily volume of 387,900 shares, the days-to-cover ratio is presently 0.3 days.
BioNexus Gene Lab Stock Performance
BGLC stock opened at $0.38 on Friday. The business has a 50 day moving average price of $0.41 and a two-hundred day moving average price of $0.49. BioNexus Gene Lab has a twelve month low of $0.31 and a twelve month high of $3.39.
BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) last issued its earnings results on Wednesday, August 14th. The company reported $0.01 EPS for the quarter. BioNexus Gene Lab had a negative return on equity of 23.07% and a negative net margin of 24.01%. The company had revenue of $1.98 million during the quarter.
Institutional Inflows and Outflows
About BioNexus Gene Lab
BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.
Featured Stories
- Five stocks we like better than BioNexus Gene Lab
- Canadian Penny Stocks: Can They Make You Rich?
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Election Stocks: How Elections Affect the Stock Market
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for BioNexus Gene Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNexus Gene Lab and related companies with MarketBeat.com's FREE daily email newsletter.